Brodimoprim

An article about the antibiotic Brodimoprim

Brodimoprim

Chemical synthesis of Brodimoprim

Brodimoprim is a synthetic antibiotic belonging to the class of diaminopyrimidines. It is structurally related to trimethoprim, another well-known antibiotic, and functions by inhibiting bacterial dihydrofolate reductase, an enzyme critical for the synthesis of tetrahydrofolate, which is necessary for bacterial DNA synthesis.

Mechanism of Action

Brodimoprim acts by selectively inhibiting the bacterial enzyme dihydrofolate reductase. This enzyme is responsible for the reduction of dihydrofolate to tetrahydrofolate, a form of folic acid that is required for the synthesis of nucleic acids and ultimately for bacterial growth and replication. By inhibiting this enzyme, brodimoprim effectively halts bacterial cell division, leading to the death of the bacteria.

Clinical Uses

Brodimoprim is used in the treatment of various bacterial infections, particularly those caused by Gram-positive bacteria. It is often used in combination with other antibiotics to enhance its efficacy and to prevent the development of antibiotic resistance.

Pharmacokinetics

Brodimoprim is well absorbed from the gastrointestinal tract and is widely distributed throughout the body. It is metabolized in the liver and excreted primarily in the urine. The drug has a relatively long half-life, which allows for less frequent dosing compared to some other antibiotics.

Side Effects

Common side effects of brodimoprim include nausea, vomiting, and rash. As with other antibiotics, there is a risk of allergic reactions and antibiotic-associated diarrhea.

Synthesis

The synthesis of brodimoprim involves the chemical modification of the pyrimidine ring to enhance its antibacterial activity. The process is depicted in the accompanying diagram, which shows the step-by-step chemical reactions involved in the synthesis of brodimoprim from its precursor compounds.

Related pages

• Trimethoprim
• Antibiotic resistance
• Dihydrofolate reductase